SE9203318D0 - Novel 3,3-diphenylpropylamines, their use and preparation - Google Patents

Novel 3,3-diphenylpropylamines, their use and preparation

Info

Publication number
SE9203318D0
SE9203318D0 SE9203318A SE9203318A SE9203318D0 SE 9203318 D0 SE9203318 D0 SE 9203318D0 SE 9203318 A SE9203318 A SE 9203318A SE 9203318 A SE9203318 A SE 9203318A SE 9203318 D0 SE9203318 D0 SE 9203318D0
Authority
SE
Sweden
Prior art keywords
compounds
preparation
methyl
formula
novel
Prior art date
Application number
SE9203318A
Other languages
English (en)
Inventor
R A Johansson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20387730&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9203318(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9203318A priority Critical patent/SE9203318D0/sv
Publication of SE9203318D0 publication Critical patent/SE9203318D0/sv
Priority to DE69317898T priority patent/DE69317898T2/de
Priority to EP93924876A priority patent/EP0667852B1/en
Priority to PCT/SE1993/000927 priority patent/WO1994011337A1/en
Priority to CA002148827A priority patent/CA2148827C/en
Priority to DK93924876T priority patent/DK0667852T3/da
Priority to US11/017,635 priority patent/USRE39667E1/en
Priority to HU9501329A priority patent/HU224916B1/hu
Priority to ES93924876T priority patent/ES2117155T3/es
Priority to US11/402,337 priority patent/USRE40851E1/en
Priority to AT93924876T priority patent/ATE164828T1/de
Priority to AU54380/94A priority patent/AU672458B2/en
Priority to JP51197794A priority patent/JP3343256B2/ja
Priority to US08/432,113 priority patent/US5559269A/en
Priority to NO951775A priority patent/NO305477B1/no
Priority to FI952179A priority patent/FI120256B/sv
Priority to US08/684,638 priority patent/US5686464A/en
Priority to HK98105466A priority patent/HK1006349A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
SE9203318A 1992-11-06 1992-11-06 Novel 3,3-diphenylpropylamines, their use and preparation SE9203318D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9203318A SE9203318D0 (sv) 1992-11-06 1992-11-06 Novel 3,3-diphenylpropylamines, their use and preparation
AU54380/94A AU672458B2 (en) 1992-11-06 1993-11-05 Novel 3,3-diphenylpropylamines, their use and preparation
JP51197794A JP3343256B2 (ja) 1992-11-06 1993-11-05 新規な３，３−ジフェニルプロピルアミン類、その使用および製造法
HU9501329A HU224916B1 (en) 1992-11-06 1993-11-05 3,3-diphenylpropylamines, pharmaceutical compositions containing them and preparation
AT93924876T ATE164828T1 (de) 1992-11-06 1993-11-05 3,3-diphenylpropylamine, ihre verwendung und herstellung
PCT/SE1993/000927 WO1994011337A1 (en) 1992-11-06 1993-11-05 Novel 3,3-diphenylpropylamines, their use and preparation
CA002148827A CA2148827C (en) 1992-11-06 1993-11-05 Novel 3,3-diphenylpropylamines, their use and preparation
DK93924876T DK0667852T3 (da) 1992-11-06 1993-11-05 Hidtil ukendte 3,3-diphenylpropylaminer samt deres anvendelse og fremstilling
US11/017,635 USRE39667E1 (en) 1992-11-06 1993-11-05 3,3-Diphenylpropylamines, their use and preparation
DE69317898T DE69317898T2 (de) 1992-11-06 1993-11-05 3,3-diphenylpropylamine, ihre verwendung und herstellung
ES93924876T ES2117155T3 (es) 1992-11-06 1993-11-05 Nuevas 3,3-difenilpropilaminas, su uso y su preparacion.
US11/402,337 USRE40851E1 (en) 1992-11-06 1993-11-05 3,3-diphenylpropylamines, their use and preparation
EP93924876A EP0667852B1 (en) 1992-11-06 1993-11-05 Novel 3,3-diphenylpropylamines, their use and preparation
FI952179A FI120256B (sv) 1992-11-06 1995-05-05 Förfarande för framställning av nya terapeutiskt aktiva 3,3-difenylpropylaminer och mellanprodukter
NO951775A NO305477B1 (no) 1992-11-06 1995-05-05 Nye 3,3-difenylpropylaminer, farmas°ytiske preparater inneholdende slike forbindelser, og deres anvendelse
US08/432,113 US5559269A (en) 1992-11-06 1995-05-05 3,3-diphenylpropylamines, their use and preparation
US08/684,638 US5686464A (en) 1992-11-06 1996-07-22 3,3-diphenylpropylamines, their use and preparation
HK98105466A HK1006349A1 (en) 1992-11-06 1998-06-17 Novel 3,3-diphenylpropylamines their use and preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9203318A SE9203318D0 (sv) 1992-11-06 1992-11-06 Novel 3,3-diphenylpropylamines, their use and preparation

Publications (1)

Publication Number Publication Date
SE9203318D0 true SE9203318D0 (sv) 1992-11-06

Family

ID=20387730

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9203318A SE9203318D0 (sv) 1992-11-06 1992-11-06 Novel 3,3-diphenylpropylamines, their use and preparation

Country Status (15)

Country Link
US (4) USRE40851E1 (sv)
EP (1) EP0667852B1 (sv)
JP (1) JP3343256B2 (sv)
AT (1) ATE164828T1 (sv)
AU (1) AU672458B2 (sv)
CA (1) CA2148827C (sv)
DE (1) DE69317898T2 (sv)
DK (1) DK0667852T3 (sv)
ES (1) ES2117155T3 (sv)
FI (1) FI120256B (sv)
HK (1) HK1006349A1 (sv)
HU (1) HU224916B1 (sv)
NO (1) NO305477B1 (sv)
SE (1) SE9203318D0 (sv)
WO (1) WO1994011337A1 (sv)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
EP0938314A1 (en) 1996-07-01 1999-09-01 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (r)-trihexyphenidyl
ATE235903T1 (de) * 1996-12-02 2003-04-15 Kyorin Seiyaku Kk Neue derivate von n-substituierten pyrrolidin derivaten und deren herstellungsverfahren
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
CZ302630B6 (cs) 1998-08-27 2011-08-10 Pharmacia & Upjohn Ab Farmaceutický prostredek obsahující tolterodin nebo tolterodinu príbuznou slouceninu
SK6412002A3 (en) 1999-11-11 2002-09-10 Pharmacia Ab Pharmaceutical formulation containing tolterodine and its use
DE19955190A1 (de) * 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
SE9904850D0 (sv) * 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
US6790854B2 (en) 2000-03-24 2004-09-14 Meiji Seika Kaisha, Ltd. Diphenylalkylamine derivatives useful as opioid receptor agonists
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10033016A1 (de) * 2000-07-07 2002-01-24 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen
PE20020547A1 (es) 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma
CN1536986B (zh) * 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的***内药物递送装置
US20030027856A1 (en) * 2001-06-29 2003-02-06 Aberg A.K. Gunnar Tolterodine metabolites
US20030060513A1 (en) * 2001-09-27 2003-03-27 Arneric Stephen P. Pharmaceutical composition
ATE418534T1 (de) * 2001-10-26 2009-01-15 Pharmacia & Upjohn Co Llc Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe
CA2464217A1 (en) * 2001-11-05 2003-05-15 Pharmacia & Upjohn Company Antimuscarinic aerosol
WO2003039524A1 (en) * 2001-11-09 2003-05-15 Pharmacia Ab Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
WO2003053428A1 (en) * 2001-12-20 2003-07-03 Pharmacia Corporation Controlled release dosage form having improved drug release properties
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US7005449B2 (en) 2002-04-23 2006-02-28 Pharmacia & Upjohn Company Tolterodine salts
CN1668585A (zh) * 2002-07-08 2005-09-14 兰贝克赛实验室有限公司 用作蝇蕈碱受体拮抗剂的3,6－二取代氮杂双环[3.1.0]己烷衍生物
US7825132B2 (en) 2002-08-23 2010-11-02 Novartis Vaccines And Diagnostics, Inc. Inhibition of FGFR3 and treatment of multiple myeloma
CA2501932C (en) 2002-11-13 2014-03-11 Chiron Corporation Use of benzimidazole quinolinones for treating cancer
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
AU2003214520A1 (en) * 2003-04-09 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
BRPI0409302A (pt) * 2003-04-11 2006-04-11 Ranbaxy Lab Ltd derivados azabiciclo como antagonistas de recetores muscarìnicos, método para sua preparação e composição farmacêutica contendo os mesmos
BRPI0409653A (pt) 2003-04-25 2006-04-25 Pharmacia & Upjohn Co Llc 3,3-difenilpropilaminas (tolterodina) substituìdas com halogênio com atividade antimuscarìnica
US7141696B2 (en) * 2003-05-23 2006-11-28 Bridge Pharma, Inc. Smooth muscle spasmolytic agents
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
EP1701932B1 (en) * 2003-12-24 2012-07-18 Cipla Ltd. Tolterodine, compositions and uses thereof, and preparation of the same
US7875624B2 (en) 2004-02-20 2011-01-25 Novartis Vaccines And Diagnostics, Inc. Modulating and measuring cellular adhesion
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
US20100035954A1 (en) * 2004-12-15 2010-02-11 Mohammad Salman Acid addition salts of muscarinic receptor antagonists
EP1843999A1 (en) * 2005-01-10 2007-10-17 Teva Pharmaceutical Industries Ltd Process for preparing tolterodine tartrate
WO2006117754A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
WO2006124413A2 (en) 2005-05-13 2006-11-23 Novartis Ag Methods for treating drug resistant cancer
EP1965863A2 (en) * 2005-12-20 2008-09-10 Pfizer Products Inc. Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
MX2008011963A (es) 2006-03-20 2008-10-01 Pfizer Ltd Derivados de amina.
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
MX2008015233A (es) * 2006-05-31 2008-12-12 Schwarz Pharma Ltd Sintesis nueva de fenoles de hidroximetileno subtituidos.
IES20060424A2 (en) 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
WO2007140986A1 (en) 2006-06-09 2007-12-13 Schwarz Pharma Ltd Synthesis of phenolic esters of hydroxymethyl phenols
KR20140010198A (ko) 2006-06-12 2014-01-23 유씨비 파마 게엠베하 새로운 키랄 중간체, 그 키랄 중간체의 제조방법 및 톨테로딘, 페소테로딘 또는 그 활성대사물질의 제조에서 그 키랄 중간체의 사용
IES20060435A2 (en) 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
EP2044001B1 (en) * 2006-06-20 2016-11-23 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-n-alkyl-3-phenylpropylamines
WO2009037569A2 (en) * 2007-09-21 2009-03-26 Actavis Group Ptc Ehf An improved process for the preparation of fesoterodine
KR101188333B1 (ko) * 2008-02-20 2012-10-09 에스케이케미칼주식회사 안정성이 우수하고 경피제로 유용한 톨테로딘 결정성산부가염
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
ES2533956T3 (es) * 2009-05-11 2015-04-16 Ratiopharm Gmbh Desfesoterodina en forma de una sal de ácido tartárico
IT1394219B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
IT1394217B1 (it) 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
EP2281801B1 (en) 2009-07-27 2014-01-08 Crystal Pharma, S.A.U. Process for obtaining 3,3-diphenylpropylamines
IT1396373B1 (it) 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
EP2364966A1 (en) 2010-03-09 2011-09-14 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
TWI590821B (zh) 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
JP6234999B2 (ja) 2012-05-04 2017-11-22 クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． 光学的に活性な３，３−ジフェニルプロピルアミンを調製するための方法
EP2760822B1 (en) 2012-06-14 2016-03-23 ratiopharm GmbH Desfesoterodine salts
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
GB201402556D0 (en) 2014-02-13 2014-04-02 Crystec Ltd Improvements relating to inhalable particles
WO2016148444A1 (ko) * 2015-03-17 2016-09-22 제이더블유중외제약 주식회사 신규 데스페소테로딘 유도체, 이의 약제학적으로 허용되는 염 및 이를 포함하는 약제학적 조성물
WO2017137955A1 (en) 2016-02-14 2017-08-17 Celestis Pharmaceuticals Pvt. Ltd. Novel (r) and rac 3-(2-(allyloxy)-5-methylphenyl)-n,n-diisopropyl-3- phenylpropan-1-amine and its use for synthesis of (r) and rac-2-(3- (diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol
CN110372571B (zh) * 2018-04-12 2022-11-15 中国科学院大连化学物理研究所 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK111894A (sv) 1962-11-15
GB1169945A (en) 1966-08-25 1969-11-05 Geistlich Soehne Ag Pharmaceutical Compositions containing Diphenylalkyl-amine Derivatives
GB1169944A (en) * 1966-08-25 1969-11-05 Geistlich Soehne Ag Novel 3,3-Diphenylpropylamines and processes for the preparation thereof
US4139537A (en) 1976-06-29 1979-02-13 Cooper Laboratories, Inc. 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) * 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
PE20020547A1 (es) * 2000-10-24 2002-06-12 Upjohn Co Uso de la tolterodina en tratamientos del asma

Also Published As

Publication number Publication date
US5686464A (en) 1997-11-11
JP3343256B2 (ja) 2002-11-11
EP0667852B1 (en) 1998-04-08
ES2117155T3 (es) 1998-08-01
CA2148827A1 (en) 1994-05-26
EP0667852A1 (en) 1995-08-23
NO951775L (no) 1995-05-05
FI952179A0 (sv) 1995-05-05
NO951775D0 (no) 1995-05-05
DK0667852T3 (da) 1999-01-11
CA2148827C (en) 2005-01-04
AU672458B2 (en) 1996-10-03
JPH08503208A (ja) 1996-04-09
US5559269A (en) 1996-09-24
USRE39667E1 (en) 2007-05-29
AU5438094A (en) 1994-06-08
USRE40851E1 (en) 2009-07-14
HUT72742A (en) 1996-05-28
DE69317898T2 (de) 1998-10-15
ATE164828T1 (de) 1998-04-15
DE69317898D1 (de) 1998-05-14
HU224916B1 (en) 2006-04-28
WO1994011337A1 (en) 1994-05-26
FI120256B (sv) 2009-08-31
HU9501329D0 (en) 1995-06-28
HK1006349A1 (en) 1999-02-19
NO305477B1 (no) 1999-06-07
FI952179A (sv) 1995-05-05

Similar Documents

Publication Publication Date Title
SE9203318D0 (sv) Novel 3,3-diphenylpropylamines, their use and preparation
NL980020I1 (nl) Nieuwe aminen, de toepassing ervan en de bereiding.
ZA932168B (en) Naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
ZA936658B (en) Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them
HK1023346A1 (en) Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them
GR3021765T3 (en) Aminoalkylchomones, process for their preparation and pharmaceutical compositions containing them.
ZA941056B (en) (Cyclohexyl)alkene compounds processes for preparing them and pharmaceutical compositions containing them
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them